Investigation of Blood Count-Based Inflammatory Biomarkers as Predictors of Response to Dupilumab Treatment in Patients with Chronic Rhinosinusitis with Nasal Polyps
Background/Objectives: Chronic rhinosinusitis with nasal polyps (CRSwNP) is a type 2 inflammatory disease often resistant to standard treatments. Dupilumab, a monoclonal antibody targeting the IL-4α receptor, has shown efficacy in CRSwNP, but a significant subset of patients do not respond to this t...
Saved in:
Main Authors: | Michael Habenbacher (Author), Ulrich Moser (Author), Ahmed Abaira (Author), Peter Kiss (Author), Clemens Holzmeister (Author), Jakob Pock (Author), Katharina Walla (Author), Angelika Lang (Author), Alexandros Andrianakis (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2024-10-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Therapeutic Potential of Dupilumab in the Treatment of Chronic Rhinosinusitis with Nasal Polyps: Evidence to Date
by: Kim J, et al.
Published: (2020) -
A social-economic burden of rhinosinusitis with nasal polyps with comorbid asthma and influence of dupilumab
by: I. S. Krysanov, et al.
Published: (2021) -
Dupilumab: Clinical Efficacy of Blocking IL-4/IL-13 Signalling in Chronic Rhinosinusitis with Nasal Polyps
by: Kariyawasam HH, et al.
Published: (2020) -
Effectiveness and Safety Profile of Dupilumab in Chronic Rhinosinusitis with Nasal Polyps: Real-Life Data in Tertiary Care
by: Cosimo Galletti, et al.
Published: (2023) -
Oxidative Stress and Antioxidants in Chronic Rhinosinusitis with Nasal Polyps
by: Junhu Tai, et al.
Published: (2023)